[Use of desmopressin in children with inherited platelet dysfunctions undergoing adenotonsillar procedures]

Raimundo J García-Matte1, M Constanza Beltran, Ximena Fonseca

  • 1Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Insights

Desmopressin effectively managed bleeding risks in pediatric adenotonsillar surgery for patients with mild inherited platelet dysfunction. This study found desmopressin to be a safe and effective prophylactic treatment, with minimal complications observed.

Area of Science:

  • Pediatric Surgery
  • Hematology
  • Pharmacology

Background:

  • Adenotonsillar surgery poses significant bleeding risks in children with inherited platelet dysfunction.
  • Existing guidelines for perioperative hemostatic management lack outcome data for this specific pediatric population.

Purpose of the Study:

  • To evaluate the efficacy and safety of desmopressin for perioperative bleeding management in children with mild inherited platelet dysfunction undergoing adenotonsillar surgery.

Main Methods:

  • Retrospective study analyzing 27 pediatric patients with mild inherited platelet dysfunction.
  • Patients received desmopressin for perioperative hemostatic management during adenotonsillar procedures.

Main Results:

  • A low rate of perioperative bleeding (3.7%) was observed.
  • One patient (3.7%) experienced transient hypotension as a desmopressin side effect.

Conclusions:

  • Desmopressin provides adequate prophylaxis against perioperative bleeding in pediatric adenotonsillar surgery for patients with mild platelet dysfunction.
  • The treatment was associated with no severe complications, indicating a favorable safety profile.
Abstract

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...